At CROI 2025, researchers from Université de Montréal discuss how fostemsavir could target residual viral fragments and reduce inflammation.
Madeleine Durand, MD, MSc
Advertisement
Associate Professor of Medicine at Univsersité de Montréal and Researcher at the CHUM Research Center.
Articles by Madeleine Durand, MD, MSc
Advertisement
Latest Updated Articles
Targeting Soluble gp120 to Combat Immune Dysfunction in People Living with HIVPublished: March 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Approves IV Antbiotic, Contepo, for Complicated Urinary Tract Infections
2
Listeria Outbreak Update: 27 Illnesses and 6 Deaths Linked to Packaged Meals
3
Clesrovimab Lowers RSV Hospitalizations and Illness in Healthy Infants
4
In A Matter of Months, MMR Vaccine Confidence Drops Significantly
5
